Clinical Trial Update: Bivalirudin Versus Heparin During PCI in High Bleeding Risk Patients With Acute Coronary Syndromes [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing bivalirudin versus heparin during percutaneous coronary intervention in high-bleeding-risk patients with acute coronary syndr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• Bivalirudin (bivalirudin)
• Heparin (unfractionated heparin)

Snippet

Sponsor: Shenyang Northern Hospital | Conditions: Percutaneous Coronary Intervention, High Bleeding Risk | Phase 4 | Status: NOT_YET_RECRUITING